Above are a pediatric unit and a chemotherapy ward, where large hospital carts are ineffective.
Since the advent of the Vascular Access program in February 2014 and December 2016, St. Joseph’s Hospital has seen a remarkable and unexpected level of cost-savings: nearly $3.5 million in total. To learn more, read Becker's article here.
Vein-Eye CARRY - Lou Gehrig's Syndrome And The Prevention Of Infiltration And Extravasation
The #1 cause for medical malpractice lawsuits, when a patient is receiving medicine from an IV, is due to the inadvertent leakage of medicine from the intended vein into the surrounding tissue.
Infiltration and Extravasation can cause a mild skin reaction, severe necrosis, infection, complex regional pain syndrome and acute limb compartment syndrome (ALCS ).
The Vein-Eye CARRY will monitor the infusion, display an image continuously on an HD monitor or a Tablet, and allow the healthcare practitioner to prevent leakage.
The Vein-Eye CARRY Tablet can be attached to a chemotherapy chair in the hospital, on a table or a desk in the home, or attached to a bed in the home or in the hospital.
A new FDA-approved drug, Radicava, demonstrated conclusively in testing that the medicine reduced the rate of decline in physical ability in patients with ALS by 33%.
Once available, Radicava will be administered through an IV, which patients can receive at an outpatient center, at their own homes, or at a healthcare provider’s office.
Competitive Advantages Of The Vein-Eye CARRY
The MSRP of the leading selling vein illumination devices range from $4,000 to $9,000.
The MSRP for the new Vein-Eye CARRY will be in the $2,499.
The Vein-Eye CARRY will perform significantly better than the competition when the patient has hair on the hand or arm, dark skin, or collapsed veins.
The Vein-Eye CARRY shows real-time video of the entire arm and hand; our competitors project a small reconstructed image back onto the arm and hand
The Vein-Eye CARRY will be used by the VNA (Visiting Nurse Association), mobile healthcare practitioners, in nursing homes, assisted living facilities, ambulances and the Emergency Room – anywhere quick and accurate vein punctures will save lives
The Vein-Eye CARRY will be used in the battlefield on night vision goggles.
The Vein-Eye CARRY solves the space problem with the NIC (Neonatal Intensive Care), the ICU, the OR, the ER and the chemotherapy infusion areas.
Portfolio Of Future Products To Be Developed With The Profits From The Vein-Eye CARRY
2018 – 2019 Optical Ultrasound Tomography™ (OUT)
Optical Ultrasound Tomography™ will detect real-time bleeding in the skull at the scene of the injury. The technology is non-contact photoacoustic imaging. The technology was developed at Lawrence Livermore National Laboratory
OUT will send the images of bleeding in the brain to a waiting neurosurgeon from the battlefield, sports venue, automobile accident or home.
2018 – 2019 NII BIO
The NII-BIO is non-contact vein-recognition biometrics using multiple modalities (fingers, palm, geometry of hand, finger and palm veins) for secure identification and authentication.
The technology was developed at Lawrence Livermore National Laboratory, the patent application has been filed, and NII has exclusive rights
NII has received rave reviews from the Dept. of Defense and the Combatant Technology scouts for its ability to image veins and its plan to develop the NII-BIO.
The Team
Michael Feeney, President, M.S., Northeastern University, Boston, MA, has twenty (20) years sales and sales management experience with optics in medicine and optical networking.
Mikhail Fridberg, MSEE, has experience in all phases of optical hardware projects including requirements definition, system design, specification, component design and Implementation and algorithm development
Ross Goldman, Financial Consultant, MBA, Babson College, Wellesley, MA, assists in the preparation of business plans, projections, tax returns and risk management.
